Pharmathen SA

This company develops complex drug delivery systems and formulations to enhance patient compliance and offer affordable, high-quality medicines globally, serving more than 250 customers across more than 90 countries including Europe, North America, South America, the Middle East and North Africa, and Asia-Pacific. Its portfolio includes more than 100 products spanning finished dosages (long-acting injectables, peptides, modified-release orals, complex ophthalmics and injectables) and APIs (peptides and others), with all products manufactured in FDA- and EU-approved GMP facilities.